Contemporary Status of Percutaneous Ablation for the Small Renal Mass

Benjamin J. Shin, Jeffrey Forris Beecham Chick, S. William Stavropoulos

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.

Original languageEnglish (US)
Article number23
Pages (from-to)1-9
Number of pages9
JournalCurrent urology reports
Issue number3
StatePublished - Mar 1 2016

All Science Journal Classification (ASJC) codes

  • Urology


Dive into the research topics of 'Contemporary Status of Percutaneous Ablation for the Small Renal Mass'. Together they form a unique fingerprint.

Cite this